Interactions among peroxisome proliferator activated receptor-γ, insulin signaling pathways, and steroidogenic acute regulatory protein in human ovarian cells

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 6, 2007, Pages 2232-2239

  Seto Young, Donna ^a,d   Avtanski, Dimiter ^a,b   Strizhevsky, Marina ^a   Parikh, Grishma ^a   Patel, Parini ^a   Kaplun, Julia ^a   Holcomb, Kevin ^a   Rosenwaks, Zev ^c   Poretsky, Leonid ^a,d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ADULT; ALPHA CHAIN; ARTICLE; BETA CHAIN; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION; GRANULOSA CELL; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; IN VITRO STUDY; OVARY CELL CULTURE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STROMA CELL; SURGICAL TECHNIQUE; THECA CELL;

EID: 34347205695     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1935     Document Type: Article

References (40)

1. Lenhard JM 2001 PPARγ/RXR as a molecular target for diabetes. Receptors Channels 7:249-258
2. Seto-Young D, Paliou M, Schlosser J, Avtanski D, Park A, Patel P, Holcomb K, Chang P, Poretsky L 2005 Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. J Clin Endocrinol Metab 90:6099-6105
3. Hammarstedt A, Smith U 2003 Thiazolidinediones (PPARγ ligands) increase IRS-1, UCP-2 and C/EBPa expression, but not transdifferentiation, in L6 muscle cell. Diabetologia 46:48-52
4. Miyazaki Y, He H, Mandario LJ, DeFronzo RA 2003 Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patients. Diabetes 52:1943-1950
5. Benkirane K, Viel EC, Amiri F, Schiffrin EL 2006 Peroxisome proliferator-activated receptor-γ regulates angiotensin II-stimulated phosphatidylinositol-3-kinase and mitogen-activated protein kinase in blood vessels in vivo. Hypertension 47:102-108
6. Gardner OS, Shiau CW, Chen CS, Grave LM 2005 Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK protein kinase: correlation with endoplasmic reticulum stress. J Biol Chem 280:10109-10118
7. Bhangoo A, Gu W-X, Pavlakis S, Anhalt H, Heier L, Ten S, Jameson JL 2005 Phenotypic features associated with mutations in steroidogenic acute regulatory protein. J Clin Endocrinol Metab 90:6303-6309
8. Manna PR, Chandrala SP, King SR, Jo Y, Counis R, Huhtaniemi IT, Stocco MD 2006 Molecular mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute regulatory protein in mouse Leydig cells. Mol Endocrinol 20:362-378
9. Balasubramanian K, Lavoie HA, Garmey JC, Stocco DM, Veldhuis JD 1997 Regulation of porcine granulosa cell steroidogenic acute regulatory protein (StAR) by insulin-like growth factor I: synergism with follicle-stimulating hormone or protein kinase A agonist. Endocrinology 138:433-439
10. Eimeral S, Orly J 2002 Regulation of steroidogenic genes by insulin-like growth factor-I and follicle-stimulating hormone: differential response of cytochrome P450 side-chain cleavage, steroidogenic acute regulatory protein, and 3-β-hydroxysteroid dehydrogenase/isomerase in rat granulosa cells. Biol Reprod 67:900-910
11. Sekar N, Lavoie HA, Veldhuis JD 2000 Concerted regulation of steroidogenic acute regulatory gene expression by luteinizing hormone and insulin (or insulin-like growth factor I) in primary culture of porcine granulosa-luteal cells. Endocrinology 141:3983-3992
12. Seto-Young D, Zajac J, Liu H-C, Rosenwaks Z, Poretsky L 2003 The role of mitogen activated protein kinase (MAPK) in insulin and IGF-I signaling cascades for progesterone and IGFBP-1 production in human granulosa cells. J Clin Endocrinol Metab 88:3385-3391
13. Seto-Young D, Leonardi O, Park A, Holcomb K, Salehi M, Chang P, Yih M, Rosenwaks Z, Poretsky L 2005 Hormonally active nontransformed human ovarian cell culture from oophorectomy specimens: methods of development and initial characterization. Horm Res 64:238-247
14. Stocco CO, Chedrese J, Deis R 2001 Luteal expression cytochrome P450 side-chain cleavage, steroidogenic acute regulatory protein, 3-β-hydroxysteroid dehydrogenase, and 20-α-hydroxysteroid dehydrogenase genes in later pregnant rats: effect of luteinizing hormone and RU486. Biol Reprod 65:1114-1119
15. Schwarzenbach H, Manna PR, Stocco DM, Charkrabarti G, Mukhopadhyay K 2003 Stimulatory effect of progesterone on the expression of steroidogenic acute regulatory protein in MA-10 Leydig cells. Biol Reprod 68:1054-1063
16. Jefcoate C 2002 High-flux mitochondrial cholesterol trafficking, a specialized function of the adrenal cortex. J Clin Invest 110:881-890
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
18. Cosgrave L, Lovrecz GO, Verkuylen A, Cavaleri L, Black LA, Bentley JD. Howlett GJ, Gray PP, Ward CW, McKern NM 1995 Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture. Protein Expr Purif 6:789-798
19. Massague J, Pilch PF, Czech MP 1980 Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc Natl Acad Sci USA 77:7137-7141
20. Trischitta V, Wong K-Y, Brunetti A, Scalisi R, Vigneri R, Goldfine ID 1989 Endocytosis, recycling, and degradation of the insulin receptor: studies with monoclonal antireceptor antibodies that do not activate receptor kinase. J Biol Chem 264:5041-5046
21. Ganderton RH, Stanley KK, Field CE, Coghlan MP, Soos MA, Siddle K 1992 A monclonal anti-peptide antibody reacting with the insulin receptor β-subunit: characterization of antibody and its epitope and use in immunoaffinity purification of intact receptors. Biochem J 288:195-205
22. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC 1999 The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20:535-582
23. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J 1976 The syndromes of insulin resistance and acanthosis nigricans: insulin-receptor disorders in man. N Engl J Med 294:739-745
24. Flier JS, Kahn CR, Roth J, Bar RS 1975 Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 190:63-65
25. Taylor SI, Dons RF, Hernandez E, Roth J, Gorden P 1982 Insulin resistance associated with androgen excess in women with auto-antibodies to the insulin receptor. Ann Intern Med 97:851-855
26. Brettenthaler N, DeGeyter C, Huber PR, Keller U 2004 Effect of the insulin sensitizer pioglitazone treatment on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89:3835-3840
27. Sepilian V, Nagamani M 2005 Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. J Clin Endocrinol Metab 90:60-65
28. Komar CM, Braissant O, Wahli W, Curry TE 2001 Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 142:4831-4838
29. Zhong WZ, Williams MG 1996 Simultaneous quantitation of pioglitazone and its metabolites in human serum by liquid chromatography and solid phase extraction. J Pharm Biomed Anal 14:465-473
30. Roa NVSM, Biju B, Mullangi R, Nuggehally RS 2003 Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard. Biomed Chromatogr 17:417-420
31. Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Carrington S, Szalkowski D, Moller DE 1996 Insulin and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor-γ. J Biol Chem 271:31771-31774
32. Prusty D, Park BH, Davis KE, Farmer SR 2002 Activation of Mek/Erk signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor-γ (PPAR-γ) and C/EBPα gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226-46232
33. Gross DN, Farmer SR, Pilch PF 2004 Glut 4 storage vesicle with Glut 4: transcriptional regulation of insulin-dependent vesicular traffic. Mol Cell Biol 24:7151-7162
34. Forsayeth JR, Montemurro A, Maddux BA, DePirro R, Goldfine ID 1987 Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J Biol Chem 262:4134-4140
35. Rouiller DG, McKeon C, Taylor SI, Gorden P 1988 Hormonal regulation of insulin receptor gene expression. J Biol Chem 263:13185-13190
36. Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID 1990 Progestin increases insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res 50:7858-7862
37. Vendola K, Zhou J, Wang J, Bondy CA 1999 Androgens promote insulin-like growth factor-I and insulin like growth factor-receptor gene expression in the primate ovary. Hum Reprod 14:2328-2332
38. De Vroede MA, Rechler MM, Nissley SP, Ogawa H, Joshi S, Burke GT, Katsoyannis PG 1986 Mitogenic activity and receptor reactivity of hybrid molecules containing portions of the insulin-like growth factor I (IGF-I), IGF-II, and insulin receptor molecules. Diabetes 35:355-361
39. Siddle K, Soos MA, Field CE, Nave BT 1994 Hybrid and atypical insulin/insulin-like growth factor I receptors. Horm Res 41(Suppl 2):56-64
40. Federici, M, Porzio, O, Zucaro L, Giovannone B, Borboni P, Marini MA, Lauro D, Sesti G 1997 Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients. Mol Cell Endocrinol 135:41-47